The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
基本信息
- 批准号:9118193
- 负责人:
- 金额:$ 31.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-05 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdenocarcinomaAffinityAnteriorAntibioticsAntralBacteriaBindingBiochemicalBiological AssayCellsChemicalsChemoreceptorsChemotaxisConfocal MicroscopyCuesDataDiseaseDisease OutcomeDrug or chemical Tissue DistributionDuodenal UlcerEngineeringEnvironmentEpithelialEpithelial CellsEpitheliumGastric GlandsGastric Parietal CellsGastritisHabitatsHealthHelicobacter InfectionsHelicobacter pyloriHumanImpairmentIndividualInfectionKnowledgeLeadLigandsMalignant NeoplasmsMeasuresMediatingMedicalMethodsMicrobial BiofilmsMovementMucous MembraneMusOrganPathogenesisPatternPerceptionPeriplasmic Binding ProteinsPopulationPropertyProteinsResearch PersonnelResolutionRoleSignal TransductionStomachStomach DiseasesStructureSurfaceSystemTestingTropismUlcerUreaVAI-2basecell motilitydensitydesignin vivo Modelinsightmonolayermutantnext generationnovelpathogenperiplasmpreventquorum sensingreceptorresponsestructural biology
项目摘要
DESCRIPTION (provided by applicant): Helicobacter pylori is a human gastric pathogen that colonizes half the world's population and causes a wide range of diseases including gastritis, ulcers, and cancer. The distribution of the bacteria in the stomach is correlated with disease outcomes, but the factors that determine this distribution are unknown. We hypothesize that chemotaxis, the ability of bacteria to sense and orient their movement in response to chemical gradients in their environment is a key determinant of H. pylori distribution in the stomach. H. pylori is ideally suited for testing the role of bacterial chemotaxis in tissue distribution, becaue it has a simple chemotaxis system with only three core chemoreceptors and it colonizes an organ with extreme chemical gradients. This proposal builds on our novel insights into the ligands and sensing mechanisms of H. pylori chemoreceptors. In this proposal, we will use structural, biophysical, and biochemical approaches to understand the precise mechanisms by which H. pylori chemoreceptors sense three key chemicals that define three important axes in the stomach environment: urea (secreted from the gastric epithelium, defining the epithelial to luminal axis), the bacterial-produced quorum sensing molecule autoinducer-2 (defining regions of high bacterial density in the gastric glands versus the overlying mucosa), and acid (produced by the parietal cells in the anterior corpus region, defining the corpus to antrum, as well as the epithelial to luminal axis in the corpus). We have engineered mutant H. pylori that are specifically defective in sensing one of these three chemicals and we have developed highly sensitive assays for quantifying H. pylori chemotactic responses. We will use these existing mutants, and others that we engineer based on our new insights into the chemosensing mechanisms, to understand how H. pylori cells organize themselves in response to chemical signals on cultured epithelial monolayers and during infection of the mouse stomach. Knowledge gained from these studies will lead to new strategies for preventing and treating H. pylori infections by altering the bacteria's distribution in the stomach. More generally, these studies will provide novel insights into how bacterial pathogens perceive and navigate the host environment, knowledge which will be crucial for designing the next generation of antibiotics that specifically target within-host properties of bacterial invaders.
描述(由申请人提供):幽门螺杆菌是一种人类胃部病原体,它寄生在世界上一半的人口中,并引起多种疾病,包括胃炎、溃疡和癌症。胃中细菌的分布与疾病结果相关,但决定这种分布的因素尚不清楚。我们假设趋化性,即细菌根据环境中的化学梯度感知和定向其运动的能力,是幽门螺杆菌在胃中分布的关键决定因素。幽门螺杆菌非常适合测试细菌趋化性在组织分布中的作用,因为它具有简单的趋化性系统,仅具有三个核心化学感受器,并且它在具有极端化学梯度的器官中定殖。该提议建立在我们对幽门螺杆菌化学感受器的配体和传感机制的新颖见解的基础上。在本提案中,我们将使用结构、生物物理和生化方法来了解幽门螺杆菌化学感受器感知三种关键化学物质的精确机制,这些化学物质定义了胃环境中的三个重要轴:尿素(从胃上皮分泌,定义了上皮到腔轴)、细菌产生的群体感应分子自诱导剂-2(定义了 胃腺与上层粘膜的细菌密度较高)和酸(由前体区域的壁细胞产生,定义了胃体到胃窦,以及胃体中的上皮到腔轴)。我们设计了突变型幽门螺杆菌,其在感知这三种化学物质之一方面存在特殊缺陷,并且我们开发了用于量化幽门螺杆菌趋化反应的高灵敏度测定法。我们将使用这些现有的突变体以及根据我们对化学传感机制的新见解设计的其他突变体,以了解幽门螺杆菌细胞如何组织自身以响应培养的上皮单层上的化学信号以及小鼠胃感染期间的化学信号。从这些研究中获得的知识将导致通过改变细菌在胃中的分布来预防和治疗幽门螺杆菌感染的新策略。更一般地说,这些研究将为细菌病原体如何感知和导航宿主环境提供新的见解,这些知识对于设计专门针对细菌入侵者的宿主内特性的下一代抗生素至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen J Guillemin其他文献
Karen J Guillemin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen J Guillemin', 18)}}的其他基金
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
- 批准号:
10227108 - 财政年份:2018
- 资助金额:
$ 31.69万 - 项目类别:
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
- 批准号:
10468041 - 财政年份:2018
- 资助金额:
$ 31.69万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
8997473 - 财政年份:2014
- 资助金额:
$ 31.69万 - 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
- 批准号:
9318540 - 财政年份:2014
- 资助金额:
$ 31.69万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
8629573 - 财政年份:2014
- 资助金额:
$ 31.69万 - 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
- 批准号:
8652710 - 财政年份:2014
- 资助金额:
$ 31.69万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
9207745 - 财政年份:2014
- 资助金额:
$ 31.69万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别: